2
Clinical Trials associated with SBK-001SBK001注射液多次给药在中国健康受试者中的 I 期耐受性、药代动力学研究。
[Translation] Phase I tolerability and pharmacokinetic study of multiple-dose SBK001 injection in healthy Chinese subjects.
主要目的:评估健康中国成年受试者多次注射不同剂量SBK001注射液后的安全性、耐受性,并确定后期试验推荐剂量。
次要目的:评估健康中国成年受试者多次注射不同剂量SBK001注射液后SBK001的药代动力学特征。
[Translation] Primary objective: To evaluate the safety and tolerability of SBK001 injection after multiple injections of different doses in healthy Chinese adult subjects, and to determine the recommended dose for later trials.
Secondary objective: To evaluate the pharmacokinetic characteristics of SBK001 after multiple injections of different doses in healthy Chinese adult subjects.
SBK001注射液单次给药在中国健康受试者中的 I 期耐受性、药代动力学研究。
[Translation] Phase I tolerability and pharmacokinetic study of a single dose of SBK001 injection in healthy Chinese subjects.
主要目的:评估健康中国成年受试者单次注射不同剂量 SBK001 注射液后的安全性、耐受性,并确定后期试验推荐剂量。
次要目的:评估健康中国成年受试者单次注射不同剂量 SBK001 注射液后SBK001的药代动力学特征。
[Translation] Primary objective: To evaluate the safety and tolerability of SBK001 injection at different doses in healthy Chinese adult subjects, and to determine the recommended dose for later trials.
Secondary objective: To evaluate the pharmacokinetic characteristics of SBK001 after a single injection of different doses of SBK001 injection in healthy Chinese adult subjects.
100 Clinical Results associated with SBK-001
100 Translational Medicine associated with SBK-001
100 Patents (Medical) associated with SBK-001
100 Deals associated with SBK-001